Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol versus placebo for wheeze in young children in primary care
2020-000313-33Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Salbutamol with Placebo (2 arms). Primary endpoint: Course of mean parent-reported respiratory symptom score over 5 days. Started May 2020; status: active.
02
Drugs
salbutamol
Beyond the preview
Go deeper on 2020-000313-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000313-33.